95 related articles for article (PubMed ID: 21036732)
21. Identification of an aptamer targeting hnRNP A1 by tissue slide-based SELEX.
Li S; Xu H; Ding H; Huang Y; Cao X; Yang G; Li J; Xie Z; Meng Y; Li X; Zhao Q; Shen B; Shao N
J Pathol; 2009 Jul; 218(3):327-36. PubMed ID: 19291713
[TBL] [Abstract][Full Text] [Related]
22. Expression of neuronal protein synuclein gamma gene as a novel marker for breast cancer prognosis.
Wu K; Quan Z; Weng Z; Li F; Zhang Y; Yao X; Chen Y; Budman D; Goldberg ID; Shi YE
Breast Cancer Res Treat; 2007 Mar; 101(3):259-67. PubMed ID: 16821081
[TBL] [Abstract][Full Text] [Related]
23. The expression analysis of periostin in human breast cancer.
Zhang Y; Zhang G; Li J; Tao Q; Tang W
J Surg Res; 2010 May; 160(1):102-6. PubMed ID: 19524268
[TBL] [Abstract][Full Text] [Related]
24. Estrogen receptor alpha and beta profiling in human breast cancer.
Balfe P; McCann A; McGoldrick A; McAllister K; Kennedy M; Dervan P; Kerin MJ
Eur J Surg Oncol; 2004 Jun; 30(5):469-74. PubMed ID: 15135471
[TBL] [Abstract][Full Text] [Related]
25. Enhanced SLC34A2 in breast cancer stem cell-like cells induces chemotherapeutic resistance to doxorubicin via SLC34A2-Bmi1-ABCC5 signaling.
Ge G; Zhou C; Ren Y; Tang X; Wang K; Zhang W; Niu L; Zhou Y; Yan Y; He J
Tumour Biol; 2016 Apr; 37(4):5049-62. PubMed ID: 26546432
[TBL] [Abstract][Full Text] [Related]
26. Gene expression patterns distinguish breast carcinomas from normal breast tissues: the Malaysian context.
Pau Ni IB; Zakaria Z; Muhammad R; Abdullah N; Ibrahim N; Aina Emran N; Hisham Abdullah N; Syed Hussain SN
Pathol Res Pract; 2010 Apr; 206(4):223-8. PubMed ID: 20097481
[TBL] [Abstract][Full Text] [Related]
27. Metastatic potential of T1 breast cancer can be predicted by the 70-gene MammaPrint signature.
Mook S; Knauer M; Bueno-de-Mesquita JM; Retel VP; Wesseling J; Linn SC; Van't Veer LJ; Rutgers EJ
Ann Surg Oncol; 2010 May; 17(5):1406-13. PubMed ID: 20094918
[TBL] [Abstract][Full Text] [Related]
28. MUC1 oncogene amplification correlates with protein overexpression in invasive breast carcinoma cells.
Lacunza E; Baudis M; Colussi AG; Segal-Eiras A; Croce MV; Abba MC
Cancer Genet Cytogenet; 2010 Sep; 201(2):102-10. PubMed ID: 20682394
[TBL] [Abstract][Full Text] [Related]
29. Primary tumour expression of the cysteine cathepsin inhibitor Stefin A inhibits distant metastasis in breast cancer.
Parker BS; Ciocca DR; Bidwell BN; Gago FE; Fanelli MA; George J; Slavin JL; Möller A; Steel R; Pouliot N; Eckhardt B; Henderson MA; Anderson RL
J Pathol; 2008 Feb; 214(3):337-46. PubMed ID: 17985332
[TBL] [Abstract][Full Text] [Related]
30. Down-regulation of claudin-2 in breast carcinomas is associated with advanced disease.
Kim TH; Huh JH; Lee S; Kang H; Kim GI; An HJ
Histopathology; 2008 Jul; 53(1):48-55. PubMed ID: 18479414
[TBL] [Abstract][Full Text] [Related]
31. Deregulated expression of p27(Kip1) in human breast cancers.
Sgambato A; Zhang YJ; Arber N; Hibshoosh H; Doki Y; Ciaparrone M; Santella RM; Cittadini A; Weinstein IB
Clin Cancer Res; 1997 Oct; 3(10):1879-87. PubMed ID: 9815577
[TBL] [Abstract][Full Text] [Related]
32. [Tbx3 upregulation may be one of the malignant biomarkers of breast cancer].
Chen ZH; Lv GM; Ji TH
Nan Fang Yi Ke Da Xue Xue Bao; 2009 Apr; 29(4):765-7. PubMed ID: 19403417
[TBL] [Abstract][Full Text] [Related]
33. [Expression and Significance of BP1 Gene and Cyclin D1 Gene in Breast Cancer].
Song YC; Fu SD; Wen XP; Ma ZH; Dang CX
Ai Zheng; 2007 Jul; 26(7):709-14. PubMed ID: 17626745
[TBL] [Abstract][Full Text] [Related]
34. Transcriptional and translational modulation of KAI1 expression in ductal carcinoma of the breast and the prognostic significance.
Malik FA; Sanders AJ; Jones AD; Mansel RE; Jiang WG
Int J Mol Med; 2009 Feb; 23(2):273-8. PubMed ID: 19148553
[TBL] [Abstract][Full Text] [Related]
35. Altered expression of exon 6 deleted progesterone receptor variant mRNA between normal human breast and breast tumour tissues.
Leygue E; Dotzlaw H; Watson PH; Murphy LC
Br J Cancer; 1999 May; 80(3-4):379-82. PubMed ID: 10408841
[TBL] [Abstract][Full Text] [Related]
36. Expression analysis and study of KLK4 in benign and malignant breast tumours.
Papachristopoulou G; Avgeris M; Scorilas A
Thromb Haemost; 2009 Feb; 101(2):381-7. PubMed ID: 19190825
[TBL] [Abstract][Full Text] [Related]
37. Psoriasin expression in mammary epithelial cells in vitro and in vivo.
Enerbäck C; Porter DA; Seth P; Sgroi D; Gaudet J; Weremowicz S; Morton CC; Schnitt S; Pitts RL; Stampl J; Barnhart K; Polyak K
Cancer Res; 2002 Jan; 62(1):43-7. PubMed ID: 11782356
[TBL] [Abstract][Full Text] [Related]
38. COX-2 expression in human breast carcinomas: correlation with clinicopathological features and prognostic molecular markers.
Miglietta A; Toselli M; Ravarino N; Vencia W; Chiecchio A; Bozzo F; Motta M; Torchio B; Bocca C
Expert Opin Ther Targets; 2010 Jul; 14(7):655-64. PubMed ID: 20536410
[TBL] [Abstract][Full Text] [Related]
39. Correlation and quantitation of microRNA aberrant expression in tissues and sera from patients with breast tumor.
Wang F; Zheng Z; Guo J; Ding X
Gynecol Oncol; 2010 Dec; 119(3):586-93. PubMed ID: 20801493
[TBL] [Abstract][Full Text] [Related]
40. The effects and mechanisms of SLC34A2 on maintaining stem cell-like phenotypes in CD147
Lv Y; Wang T; Fan J; Zhang Z; Zhang J; Xu C; Li Y; Zhao G; He C; Meng H; Yang H; Wang Z; Liu J; Chen J; Wang L
Tumour Biol; 2017 Apr; 39(4):1010428317695927. PubMed ID: 28381172
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
